New endometriosis drug shows promising early trial results

Endometriosis affects around 190 million women worldwide and is sometimes called a "neglected disease." The modified drug targets cells responsible for the characteristic disease changes. Early results published in Nature are promising, though scientists note the treatment requires further clinical testing.